.png){kind=icon}
.png){kind=icon}
Return
Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial
.png){kind=icon}
OA
AI
D
F
S
A
A
A
Q
J
M
G
DOI：10.1093/cid/ciag349.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Dengue is caused by infection with 1 of 4 dengue virus (DENV) serotypes (DENV-1 to DENV-4). V181 and Butantan-Dengue Vaccine (Butantan-DV) are independently developed, single-dose, quadrivalent dengue vaccines based on the same attenuated parental strains.
Journal
IF:
7.3
Papers:
2.6W
Citations:
7.8W
Organization
Cited Papers